Sigue la actividad de operaciones con información privilegiada más reciente de Outlook Therapeutics. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Outlook Therapeutics.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Sep 30, 2024 | CHIEF FINANCIAL OFFICER | 5.00K | $5.69 | $28.45K | BUY | 528.54% | 5.95K | Sep 26 | ||
Apr 17, 2024 | — | 714.29K | $0.00 | $0.00 | BUY | 72.07% | 1.71M | Apr 15 | ||
Mar 29, 2024 | — | 1.88K | $11.82 | $22.24K | BUY | 59.42% | 5.05K | Mar 28 | ||
Mar 11, 2024 | CHIEF COMMERCIAL OFFICER | 62.48K | $0.42 | $26.24K | BUY | 8.38% | 808.46K | Mar 07 | ||
Apr 21, 2023 | CHIEF OPERATIONS OFFICER | -520.00K | $1.14 | -$590.20K | SELL | -44.33% | 653.06K | Apr 20 | ||
Jan 24, 2023 | CHIEF COMMERCIAL OFFICER | -267.00K | $1.11 | -$296.37K | SELL | -26.36% | 745.98K | Jan 20 | ||
Jan 19, 2023 | CHIEF COMMERCIAL OFFICER | -164.16K | $1.24 | -$203.73K | SELL | -13.95% | 1.01M | Jan 17 - Jan 19 | ||
Oct 11, 2022 | DIRECTOR | 30.00K | $1.29 | $38.70K | BUY | 78.95% | 68.00K | Oct 07 | ||
Oct 11, 2022 | DIRECTOR | 33.34K | $1.29 | $42.94K | BUY | 111.14% | 63.34K | Oct 06 - Oct 07 | ||
Oct 05, 2022 | DIRECTOR | 111.20K | $1.28 | $142.51K | BUY | 30.73% | 473.12K | Oct 04 - Oct 05 | ||
Oct 03, 2022 | DIRECTOR | 88.80K | $1.24 | $110.50K | BUY | 32.51% | 361.91K | Sep 29 - Oct 03 | ||
Jun 23, 2022 | CHIEF OPERATING OFFICER | 10.00K | $1.05 | $10.50K | BUY | 0.86% | 1.17M | Jun 21 | ||
Jun 23, 2022 | CEO AND PRESIDENT | 19.93K | $1.06 | $21.12K | BUY | 56.93% | 54.92K | Jun 21 | ||
Mar 03, 2022 | DIRECTOR | 27.71K | $1.69 | $46.83K | BUY | 11.29% | 273.12K | Mar 01 | ||
Feb 28, 2022 | DIRECTOR | 47.16K | $1.48 | $69.69K | BUY | 23.79% | 245.41K | Feb 24 - Feb 28 | ||
Feb 23, 2022 | DIRECTOR | 175.13K | $1.47 | $256.97K | BUY | 757.59% | 198.25K | Feb 22 - Feb 23 | ||
Dec 06, 2021 | CEO AND PRESIDENT | 25.00K | $1.39 | $34.75K | BUY | 250.00% | 35.00K | Dec 06 | ||
Dec 06, 2021 | CHIEF OPERATING OFFICER | 25.20K | $1.38 | $34.78K | BUY | 2.21% | 1.16M | Dec 06 | ||
Dec 06, 2021 | CHIEF COMMERCIAL OFFICER | 35.20K | $1.34 | $47.17K | BUY | 3.08% | 1.18M | Dec 03 | ||
Dec 03, 2021 | CHIEF OPERATING OFFICER | 10.00K | $1.42 | $14.20K | BUY | 0.89% | 1.14M | Dec 03 | ||
Dec 02, 2021 | DIRECTOR | 10.00K | $1.39 | $13.90K | BUY | 50.00% | 30.00K | Dec 02 | ||
Dec 02, 2021 | DIRECTOR | 18.00K | $1.40 | $25.20K | BUY | 90.00% | 38.00K | Dec 02 | ||
Dec 02, 2021 | CEO AND PRESIDENT | 10.00K | $1.40 | $14.00K | BUY | ∞ | 10.00K | Dec 02 | ||
Dec 01, 2021 | DIRECTOR | 16.00M | $1.25 | $20.00M | BUY | 25.48% | 78.80M | Nov 29 | ||
Apr 20, 2021 | DIRECTOR | 10.00K | $1.82 | $18.20K | BUY | 100.00% | 20.00K | Apr 19 | ||
Apr 20, 2021 | DIRECTOR | 10.00K | $1.82 | $18.20K | BUY | 100.00% | 20.00K | Apr 19 | ||
Apr 20, 2021 | CEO, PRES, CFO, TREAS & SECY | 10.00K | $1.83 | $18.30K | BUY | 112.03% | 18.93K | Apr 20 | ||
Feb 25, 2021 | CHIEF COMMERCIAL OFFICER | -8.55K | $2.09 | -$17.86K | SELL | -0.74% | 1.14M | Feb 23 | ||
Feb 25, 2021 | CHIEF OPERATING OFFICER | -15.90K | $2.09 | -$33.20K | SELL | -1.39% | 1.13M | Feb 23 | ||
Feb 17, 2021 | CHIEF COMMERCIAL OFFICER | -56.97K | $2.55 | -$145.28K | SELL | -4.72% | 1.15M | Feb 12 | ||
Feb 17, 2021 | CHIEF OPERATING OFFICER | -63.70K | $2.55 | -$162.44K | SELL | -5.28% | 1.14M | Feb 12 | ||
Feb 04, 2021 | 10% OWNER | 3.00M | $1.00 | $3.00M | BUY | 17.83% | 19.82M | Feb 03 | ||
Feb 02, 2021 | DIRECTOR | 8.36M | $1.00 | $8.36M | BUY | 34.74% | 32.43M | Feb 02 |
Explora operaciones con información privilegiada sobre todos los valores.